These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21534335)
1. Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates. Turan O; Ergenekon E; Hirfanoğlu IM; Onal EE; Baş VN; Türkyilmaz C; Koç E; Atalay Y Turk J Pediatr; 2011; 53(1):19-26. PubMed ID: 21534335 [TBL] [Abstract][Full Text] [Related]
2. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408 [TBL] [Abstract][Full Text] [Related]
3. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight. Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222 [TBL] [Abstract][Full Text] [Related]
4. Caspofungin for the treatment of azole resistant candidemia in a premature infant. Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048 [TBL] [Abstract][Full Text] [Related]
5. Breakthrough candida Infection in a preterm infant with congenital cutaneous Candida albicans infection. Adler A; Litmanovitz I; Regev R; Arnon S; Bauer S; Dolfin T Am J Perinatol; 2005 Apr; 22(3):169-72. PubMed ID: 15838753 [TBL] [Abstract][Full Text] [Related]
6. [Sepsis by Candida in VLBW neonates: therapy with liposomal Amphotericin B]. Occhipinti E; Caravello T; Ciminello N; Di Pietro A; Lima G; Machì A; Raia GM; Scarfia MF; Spinto C; Vaccaro PG; Rizzo A Pediatr Med Chir; 2004; 26(1):57-60. PubMed ID: 15529814 [TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations of candidemia. Oude Lashof AM; Rothova A; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Schlamm HT; Oborska IT; Rex JH; Kullberg BJ Clin Infect Dis; 2011 Aug; 53(3):262-8. PubMed ID: 21765074 [TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B in neonates with invasive candidiasis. Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206 [TBL] [Abstract][Full Text] [Related]
9. Candida endophthalmitis: focus on current and future antifungal treatment options. Khan FA; Slain D; Khakoo RA Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891 [TBL] [Abstract][Full Text] [Related]
10. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed. Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210 [TBL] [Abstract][Full Text] [Related]
12. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia. Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202 [TBL] [Abstract][Full Text] [Related]
13. Experience with caspofungin in the treatment of persistent fungemia in neonates. Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348 [TBL] [Abstract][Full Text] [Related]
15. Successful caspofungin treatment of persistent candidemia in extreme prematurity at 23 and 24 weeks' gestation. Jeon GW; Sin JB J Formos Med Assoc; 2014 Mar; 113(3):191-4. PubMed ID: 24534016 [TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates. Manzoni P; Galletto P; Rizzollo S; Franco C; Gallo E; Antonucci R; Fanos V; Farina D Early Hum Dev; 2012 May; 88 Suppl 2():S86-91. PubMed ID: 22633524 [TBL] [Abstract][Full Text] [Related]
17. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study. Arrieta AC; Shea K; Dhar V; Cleary JP; Kukreja S; Morris M; Vargas-Shiraishi OM; Ashouri N; Singh J Clin Ther; 2010 Feb; 32(2):265-71. PubMed ID: 20206784 [TBL] [Abstract][Full Text] [Related]
18. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088 [TBL] [Abstract][Full Text] [Related]
19. The role of voriconazole in the treatment of central nervous system blastomycosis. Ta M; Flowers SA; Rogers PD Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015 [TBL] [Abstract][Full Text] [Related]